White Papers

Finance Transformation in the Pharmaceutical Industry

Finance Transformation in the Pharmaceutical Industry

This whitepaper, courtesy of RSM, tackles the increasingly complex pharmaceutical business model from the R&D and pre-clinical phase, through FDA approval and commercialization.

The Economic Footprint of the Pharmaceutical Industry – Regional Breakdown and Differentiation between Originators and Generics

The Economic Footprint of the Pharmaceutical Industry – Regional Breakdown and Differentiation between Originators and Generics

This study independently conducted by WifOR reveals how the pharmaceutical industry, one of the world’s largest industries, plays a major role in boosting the global economy across regions. This study was commissioned by the IFPMA and aims to refine the study on ‘Measuring the economic footprint of the pharmaceutical industry – Feasibility study’ that examined for the first time the global economic importance of the pharma industry.